(Q37287166)

19 August 2017

1 reference

title

Cytokine-based transformation of immune surveillance into tumor-promoting inflammation (English)

1 reference

19 August 2017

0 references

J B Mumm

1

1 reference

PubMed ID

18836472

19 August 2017

M Oft

series ordinal

2

1 reference

PubMed ID

18836472

19 August 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

19 August 2017

1 reference

19 August 2017

27

1 reference

19 August 2017

5913-5919

1 reference

19 August 2017

45

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2008.275

19 August 2017

0 references

cites work

Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Interleukin 6 is required for the development of collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Regulated expression of gp130 and IL-6 receptor alpha chain in T cell maturation and activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

The role of tumor stroma in the interaction between tumor and immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Requirement for transforming growth factor beta1 in controlling T cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

TGF-beta signaling in tumor suppression and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Angiogenesis: an organizing principle for drug discovery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Antigen-specific immunotherapy and cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Interleukin-17 family members and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Swords into plowshares: IL-23 repurposes tumor immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

IL-23 promotes tumour incidence and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

TGF-β signaling in T cells: roles in lymphoid and epithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Transforming growth factor-beta regulation of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

A cytokine-mediated link between innate immunity, inflammation, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Induction of a distinct CD8 Tnc17 subset by transforming growth factor-beta and interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Antitumor and antimetastatic activity of IL-23

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Transforming growth factor-beta induces development of the T(H)17 lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Tumor necrosis factor, cancer and anticancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

The role of IL-12, IL-23 and IFN-gamma in immunity to viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Metastasis is driven by sequential elevation of H-ras and Smad2 levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Interleukin-6 and prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Tumour necrosis factor-alpha as a tumour promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Interleukin-12 and the regulation of innate resistance and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Tumor-specific shared antigenic peptides recognized by human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Transforming growth factor type beta induces monocyte chemotaxis and growth factor production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Development, cytokine profile and function of human interleukin 17-producing helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Inducible expression of H-2 and Ia antigens on brain cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Transforming growth factor-beta and the immune response: implications for anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Blockade of interleukin 6 trans signaling suppresses T-cell resistanceagainst apoptosis in chronic intestinal inflammation: Evidence in Crohn diseaseand experimental colitis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Microarray Analysis of p53-Mediated Transcription: Mutli-Thousand Piece Puzzle or Invitation to Collective Thinking?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Tumor Necrosis Factor α As a New Target for Renal Cell Carcinoma: Two Sequential Phase II Trials of Infliximab at Standard and High Dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Interleukin-17 promotes angiogenesis and tumor growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Prevalence of malignancy in psoriatic arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

Evaluation of TNF-alpha and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-alpha/anti-CD4 therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.275

31 March 2020

Identifiers

DOI

10.1038/ONC.2008.275

1 reference

19 August 2017

1 reference

PubMed ID

18836472